{"transactions":[{"id":858096,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:29:50.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":3559,"price":40.9889,"value":145879.4951,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.84 to $41.35, inclusive."}],"balance_after":71770,"source":{"system":"sec-edgar","filing":"0001746251-26-000004","document":"form4-03052026_090346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625126000004/form4-03052026_090346.xml","form_type":"4"}},{"id":858095,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:29:50.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":46417,"price":40.3636,"value":1873557.2212,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.835 to $40.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":75329,"source":{"system":"sec-edgar","filing":"0001746251-26-000004","document":"form4-03052026_090346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625126000004/form4-03052026_090346.xml","form_type":"4"}},{"id":907376,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:09.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":21615,"price":46.75,"value":1010501.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs."}],"balance_after":121746,"source":{"system":"sec-edgar","filing":"0001746251-26-000002","document":"form4-02122026_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625126000002/form4-02122026_040201.xml","form_type":"4"}},{"id":907375,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:09.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":9977,"price":46.75,"value":466424.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs."}],"balance_after":143361,"source":{"system":"sec-edgar","filing":"0001746251-26-000002","document":"form4-02122026_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625126000002/form4-02122026_040201.xml","form_type":"4"}},{"id":907374,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:09.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":30702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 30,702 performance share units (\"PSUs\") granted in the Issuer's three prior fiscal years."}],"balance_after":153338,"source":{"system":"sec-edgar","filing":"0001746251-26-000002","document":"form4-02122026_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625126000002/form4-02122026_040201.xml","form_type":"4"}},{"id":907373,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:09.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":19023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock."}],"balance_after":122636,"source":{"system":"sec-edgar","filing":"0001746251-26-000002","document":"form4-02122026_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625126000002/form4-02122026_040201.xml","form_type":"4"}},{"id":974317,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-12-10T21:32:40.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":false,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.9,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001746251-25-000004","document":"form4-12102025_091236.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625125000004/form4-12102025_091236.xml","form_type":"4"}},{"id":974316,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-10T21:32:40.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":6475,"price":48.6617,"value":315084.5075,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.215 to $49.08, inclusive."}],"balance_after":103613,"source":{"system":"sec-edgar","filing":"0001746251-25-000004","document":"form4-12102025_091236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625125000004/form4-12102025_091236.xml","form_type":"4"}},{"id":974315,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-10T21:32:40.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":11125,"price":47.8895,"value":532770.6875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.212 to $48.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":110088,"source":{"system":"sec-edgar","filing":"0001746251-25-000004","document":"form4-12102025_091236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625125000004/form4-12102025_091236.xml","form_type":"4"}},{"id":974314,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-10T21:32:40.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":true,"shares":17600,"price":15.9,"value":279840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025."}],"balance_after":121213,"source":{"system":"sec-edgar","filing":"0001746251-25-000004","document":"form4-12102025_091236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625125000004/form4-12102025_091236.xml","form_type":"4"}},{"id":1060101,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-08-20T20:57:07.000Z","date":"2025-08-18","kind":"exercise","planned":true,"acquired":false,"shares":16389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":21.34,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":16389},"source":{"system":"sec-edgar","filing":"0001062993-25-014766","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325014766/form4.xml","form_type":"4"}},{"id":1060100,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-20T20:57:07.000Z","date":"2025-08-18","kind":"sale","planned":true,"acquired":false,"shares":16389,"price":38.2068,"value":626171.2452,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.00 to $38.465, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":103613,"source":{"system":"sec-edgar","filing":"0001062993-25-014766","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325014766/form4.xml","form_type":"4"}},{"id":1060099,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-20T20:57:07.000Z","date":"2025-08-18","kind":"exercise","planned":true,"acquired":true,"shares":16389,"price":21.34,"value":349741.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."}],"balance_after":120002,"source":{"system":"sec-edgar","filing":"0001062993-25-014766","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325014766/form4.xml","form_type":"4"}},{"id":1065186,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-08-15T21:08:54.000Z","date":"2025-08-13","kind":"exercise","planned":true,"acquired":false,"shares":4861,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":16389,"derivative":{"exercise_price":21.34,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":4861},"source":{"system":"sec-edgar","filing":"0001062993-25-014526","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325014526/form4.xml","form_type":"4"}},{"id":1065185,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-15T21:08:54.000Z","date":"2025-08-13","kind":"sale","planned":true,"acquired":false,"shares":4861,"price":38.0335,"value":184880.8435,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.00 to $38.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":103613,"source":{"system":"sec-edgar","filing":"0001062993-25-014526","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325014526/form4.xml","form_type":"4"}},{"id":1065184,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-15T21:08:54.000Z","date":"2025-08-13","kind":"exercise","planned":true,"acquired":true,"shares":4861,"price":21.34,"value":103733.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."}],"balance_after":108474,"source":{"system":"sec-edgar","filing":"0001062993-25-014526","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325014526/form4.xml","form_type":"4"}},{"id":1193302,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-24T21:05:13.000Z","date":"2025-03-21","kind":"sale","planned":true,"acquired":false,"shares":18881,"price":30.0293,"value":566983.2133,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.48, inclusive."}],"balance_after":103613,"source":{"system":"sec-edgar","filing":"0001062993-25-006148","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325006148/form4.xml","form_type":"4"}},{"id":1193301,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-24T21:05:13.000Z","date":"2025-03-20","kind":"sale","planned":true,"acquired":false,"shares":1927,"price":30.0005,"value":57810.9635,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":122494,"source":{"system":"sec-edgar","filing":"0001062993-25-006148","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325006148/form4.xml","form_type":"4"}},{"id":1199276,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-18T23:18:19.000Z","date":"2025-03-11","kind":"sale","planned":true,"acquired":false,"shares":15387,"price":30.004,"value":461671.548,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The original Form 4 filed on March 13, 2025 on behalf of the Reporting Person inadvertently reported the incorrect transaction date. As reported in this amendment, the correct transaction date is March 11, 2025."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4."}],"balance_after":126676,"source":{"system":"sec-edgar","filing":"0001062993-25-005834","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325005834/form4a.xml","form_type":"4/A","original_submission_date":"2025-03-13"}},{"id":1199275,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-18T21:34:13.000Z","date":"2025-03-14","kind":"sale","planned":true,"acquired":false,"shares":2255,"price":30.0049,"value":67661.0495,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":124421,"source":{"system":"sec-edgar","filing":"0001062993-25-005752","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325005752/form4.xml","form_type":"4"}},{"id":1207536,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-13T20:50:14.000Z","date":"2025-03-06","kind":"sale","planned":true,"acquired":false,"shares":15387,"price":30.004,"value":461671.548,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":126676,"source":{"system":"sec-edgar","filing":"0001062993-25-005396","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325005396/form4.xml","form_type":"4"}},{"id":1214869,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-10T20:01:39.000Z","date":"2025-03-07","kind":"sale","planned":true,"acquired":false,"shares":2348,"price":30.0025,"value":70445.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive."}],"balance_after":142063,"source":{"system":"sec-edgar","filing":"0001062993-25-005020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325005020/form4.xml","form_type":"4"}},{"id":1214868,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-10T20:01:39.000Z","date":"2025-03-06","kind":"sale","planned":true,"acquired":false,"shares":3295,"price":30.0011,"value":98853.6245,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":144411,"source":{"system":"sec-edgar","filing":"0001062993-25-005020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325005020/form4.xml","form_type":"4"}},{"id":1271335,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-12T21:10:22.000Z","date":"2025-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":21670,"price":30.52,"value":661368.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs."}],"balance_after":147706,"source":{"system":"sec-edgar","filing":"0001062993-25-002179","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325002179/form4.xml","form_type":"4"}},{"id":1271334,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-12T21:10:22.000Z","date":"2025-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":7953,"price":30.52,"value":242725.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs."}],"balance_after":169376,"source":{"system":"sec-edgar","filing":"0001062993-25-002179","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325002179/form4.xml","form_type":"4"}},{"id":1271333,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-12T21:10:22.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":26411,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Effective February 10, 2025, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 26,411 performance share units (\"PSUs\") granted in the Issuer's three prior fiscal years."}],"balance_after":177329,"source":{"system":"sec-edgar","filing":"0001062993-25-002179","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325002179/form4.xml","form_type":"4"}},{"id":1271332,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-12T21:10:22.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":45016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2026, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock."}],"balance_after":150918,"source":{"system":"sec-edgar","filing":"0001062993-25-002179","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325002179/form4.xml","form_type":"4"}},{"id":1500183,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2024-05-28T20:22:47.000Z","date":"2024-05-24","kind":"exercise","planned":false,"acquired":false,"shares":23791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":24.03,"expiration_date":"2028-04-04","underlying":"Common Stock","underlying_shares":23791},"source":{"system":"sec-edgar","filing":"0001062993-24-011338","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324011338/form4.xml","form_type":"4"}},{"id":1500182,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2024-05-28T20:22:47.000Z","date":"2024-05-23","kind":"exercise","planned":false,"acquired":false,"shares":51209,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":23791,"derivative":{"exercise_price":24.03,"expiration_date":"2028-04-04","underlying":"Common Stock","underlying_shares":51209},"source":{"system":"sec-edgar","filing":"0001062993-24-011338","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324011338/form4.xml","form_type":"4"}},{"id":1500181,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-28T20:22:47.000Z","date":"2024-05-24","kind":"sale","planned":false,"acquired":false,"shares":56807,"price":33.9827,"value":1930455.2389,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.68 to $34.25, inclusive."}],"balance_after":105902,"source":{"system":"sec-edgar","filing":"0001062993-24-011338","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324011338/form4.xml","form_type":"4"}},{"id":1500180,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-28T20:22:47.000Z","date":"2024-05-24","kind":"exercise","planned":false,"acquired":true,"shares":23791,"price":24.03,"value":571697.73,"ownership":{"direct":true},"balance_after":162709,"source":{"system":"sec-edgar","filing":"0001062993-24-011338","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324011338/form4.xml","form_type":"4"}},{"id":1500179,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-28T20:22:47.000Z","date":"2024-05-23","kind":"sale","planned":false,"acquired":false,"shares":51209,"price":33.824,"value":1732093.216,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.36 to $34.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4."}],"balance_after":138918,"source":{"system":"sec-edgar","filing":"0001062993-24-011338","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324011338/form4.xml","form_type":"4"}},{"id":1500178,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-28T20:22:47.000Z","date":"2024-05-23","kind":"exercise","planned":false,"acquired":true,"shares":51209,"price":24.03,"value":1230552.27,"ownership":{"direct":true},"balance_after":190127,"source":{"system":"sec-edgar","filing":"0001062993-24-011338","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324011338/form4.xml","form_type":"4"}},{"id":1611988,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-02-28T21:14:24.000Z","date":"2024-02-26","kind":"sale","planned":true,"acquired":false,"shares":664,"price":37.153,"value":24669.592,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.01 to $37.50, inclusive."}],"balance_after":138918,"source":{"system":"sec-edgar","filing":"0001062993-24-004754","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324004754/form4.xml","form_type":"4"}},{"id":1611987,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-02-28T21:14:24.000Z","date":"2024-02-26","kind":"sale","planned":true,"acquired":false,"shares":9336,"price":36.3754,"value":339600.7344,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.96 to $36.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":139582,"source":{"system":"sec-edgar","filing":"0001062993-24-004754","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324004754/form4.xml","form_type":"4"}},{"id":1642832,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-02-14T21:14:56.000Z","date":"2024-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":10145,"price":33.7,"value":341886.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs."}],"balance_after":148918,"source":{"system":"sec-edgar","filing":"0001062993-24-003169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324003169/form4.xml","form_type":"4"}},{"id":1642831,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-02-14T21:14:56.000Z","date":"2024-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":19545,"price":33.7,"value":658666.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs."}],"balance_after":159063,"source":{"system":"sec-edgar","filing":"0001062993-24-003169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324003169/form4.xml","form_type":"4"}},{"id":1642830,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-02-14T21:14:56.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":32286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Effective February 12, 2024, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 32,286 performance share units (\"PSUs\") granted in the Issuer's three prior fiscal years."}],"balance_after":178608,"source":{"system":"sec-edgar","filing":"0001062993-24-003169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324003169/form4.xml","form_type":"4"}},{"id":1642829,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-02-14T21:14:56.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2025, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock."}],"balance_after":146322,"source":{"system":"sec-edgar","filing":"0001062993-24-003169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324003169/form4.xml","form_type":"4"}},{"id":1676169,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-01-18T21:19:10.000Z","date":"2024-01-16","kind":"sale","planned":true,"acquired":false,"shares":23560,"price":32.2801,"value":760519.156,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.01 to $32.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":111322,"source":{"system":"sec-edgar","filing":"0001062993-24-001028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324001028/form4.xml","form_type":"4"}},{"id":1972559,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T21:08:02.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":13324,"price":26.7,"value":355750.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.22 to $27.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2)."}],"balance_after":134882,"source":{"system":"sec-edgar","filing":"0001062993-23-005854","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299323005854/form4.xml","form_type":"4"}},{"id":2015767,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-02-14T22:15:57.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":6797,"price":26.75,"value":181819.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units."}],"balance_after":148206,"source":{"system":"sec-edgar","filing":"0001062993-23-003474","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299323003474/form4.xml","form_type":"4"}},{"id":2015766,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-02-14T22:15:57.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":14529,"price":26.75,"value":388650.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":155003,"source":{"system":"sec-edgar","filing":"0001062993-23-003474","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299323003474/form4.xml","form_type":"4"}},{"id":2015765,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-02-14T22:15:57.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":22459,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Effective February 10, 2023, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 22,459 performance share units granted in the issuer's three prior fiscal years."}],"balance_after":169532,"source":{"system":"sec-edgar","filing":"0001062993-23-003474","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299323003474/form4.xml","form_type":"4"}},{"id":2015764,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-02-14T22:15:57.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":44275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":147073,"source":{"system":"sec-edgar","filing":"0001062993-23-003474","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299323003474/form4.xml","form_type":"4"}},{"id":2056385,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-01-11T21:06:03.000Z","date":"2023-01-09","kind":"sale","acquired":false,"shares":69,"price":28.58,"value":1972.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2022."}],"balance_after":102798,"source":{"system":"sec-edgar","filing":"0001062993-23-000826","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299323000826/form4.xml","form_type":"4"}},{"id":2056384,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-01-11T21:06:03.000Z","date":"2023-01-09","kind":"sale","acquired":false,"shares":7341,"price":27.83,"value":204300.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.49 to $28.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3)."}],"balance_after":102867,"source":{"system":"sec-edgar","filing":"0001062993-23-000826","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299323000826/form4.xml","form_type":"4"}},{"id":2056383,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-01-11T21:06:03.000Z","date":"2023-01-09","kind":"sale","acquired":false,"shares":10424,"price":27.08,"value":282281.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.49 to $27.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2)."}],"balance_after":110208,"source":{"system":"sec-edgar","filing":"0001062993-23-000826","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299323000826/form4.xml","form_type":"4"}},{"id":2207973,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-07-13T20:50:17.000Z","date":"2022-07-11","kind":"tax_withholding","acquired":false,"shares":594,"price":17.48,"value":10383.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":120632,"source":{"system":"sec-edgar","filing":"0001062993-22-016312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299322016312/form4.xml","form_type":"4"}},{"id":2368626,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-02-28T21:24:04.000Z","date":"2022-02-18","kind":"sale","acquired":false,"shares":10559,"price":21.61,"value":228179.99,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Form 4 is being filed late due to an administrative error."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2021 and amended on September 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.22 to $21.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."}],"balance_after":121226,"source":{"system":"sec-edgar","filing":"0001062993-22-005911","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299322005911/form4.xml","form_type":"4"}},{"id":2397576,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-02-14T23:36:20.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":4016,"price":17.63,"value":70802.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units."}],"balance_after":131785,"source":{"system":"sec-edgar","filing":"0001062993-22-004318","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299322004318/form4.xml","form_type":"4"}},{"id":2397575,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-02-14T23:36:20.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":6643,"price":17.63,"value":117116.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":135801,"source":{"system":"sec-edgar","filing":"0001062993-22-004318","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299322004318/form4.xml","form_type":"4"}},{"id":2397574,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-02-14T23:36:20.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":13675,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 10, 2022, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 13,675 performance share units granted in the issuer's three prior fiscal years."}],"balance_after":142444,"source":{"system":"sec-edgar","filing":"0001062993-22-004318","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299322004318/form4.xml","form_type":"4"}},{"id":2397573,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-02-14T23:36:20.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2023, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":128769,"source":{"system":"sec-edgar","filing":"0001062993-22-004318","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299322004318/form4.xml","form_type":"4"}},{"id":2436680,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-01-12T21:22:23.000Z","date":"2022-01-10","kind":"tax_withholding","acquired":false,"shares":701,"price":19.05,"value":13354.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":76269,"source":{"system":"sec-edgar","filing":"0001879789-22-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000187978922000002/primary_doc.xml","form_type":"4"}},{"id":2465697,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-12-17T21:33:22.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":5693,"price":18.33,"value":104352.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2021 and amended on September 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.95 to $18.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":76970,"source":{"system":"sec-edgar","filing":"0001879789-21-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000187978921000022/primary_doc.xml","form_type":"4"}},{"id":2633980,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-07-14T20:17:43.000Z","date":"2021-07-12","kind":"tax_withholding","acquired":false,"shares":595,"price":23.17,"value":13786.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":82663,"source":{"system":"sec-edgar","filing":"0001104659-21-092117","document":"tm2122232-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000110465921092117/tm2122232-1_4seq1.xml","form_type":"4"}},{"id":2862834,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-02-12T21:16:59.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":5798,"price":25.33,"value":146863.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2020"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.01 to $25.95, inclusive."}],"balance_after":83258,"source":{"system":"sec-edgar","filing":"0001192482-21-000151","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000151/edgar.xml","form_type":"4"}},{"id":2862833,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-02-12T21:16:59.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":2100,"price":24.89,"value":52269.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2020"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.66 to $25.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5)."}],"balance_after":89056,"source":{"system":"sec-edgar","filing":"0001192482-21-000151","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000151/edgar.xml","form_type":"4"}},{"id":2862832,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-02-12T21:16:59.000Z","date":"2021-02-10","kind":"tax_withholding","acquired":false,"shares":3283,"price":25.95,"value":85193.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":91156,"source":{"system":"sec-edgar","filing":"0001192482-21-000151","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000151/edgar.xml","form_type":"4"}},{"id":2862831,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-02-12T21:16:59.000Z","date":"2021-02-10","kind":"tax_withholding","acquired":false,"shares":1901,"price":25.95,"value":49330.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of performance stock units."}],"balance_after":94439,"source":{"system":"sec-edgar","filing":"0001192482-21-000151","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000151/edgar.xml","form_type":"4"}},{"id":2899003,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-01-22T21:10:57.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":6165,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 19, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 6,165 performance share units granted in two prior years."}],"balance_after":96340,"source":{"system":"sec-edgar","filing":"0001192482-21-000098","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000098/edgar.xml","form_type":"4/A","original_submission_date":"2021-01-21"}},{"id":2899002,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-01-22T21:10:57.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":45780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2022, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":90175,"source":{"system":"sec-edgar","filing":"0001192482-21-000098","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000098/edgar.xml","form_type":"4/A","original_submission_date":"2021-01-21"}},{"id":2900530,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-01-21T21:31:15.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":130800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2022, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":130800,"derivative":{"exercise_price":24.06,"expiration_date":"2031-01-19","underlying":"Common Stock","underlying_shares":130800},"source":{"system":"sec-edgar","filing":"0001192482-21-000087","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000087/edgar.xml","form_type":"4"}},{"id":2900529,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-01-21T21:31:15.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":6165,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 19, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 6,165 performance share units granted in two prior years."}],"balance_after":96340,"source":{"system":"sec-edgar","filing":"0001192482-21-000087","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000087/edgar.xml","form_type":"4"}},{"id":2900528,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-01-21T21:31:15.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":45780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2022, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":90175,"source":{"system":"sec-edgar","filing":"0001192482-21-000087","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000087/edgar.xml","form_type":"4"}},{"id":2901945,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-01-20T21:15:26.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":1322,"price":22.89,"value":30260.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2020 and amended on December 7, 2020."}],"balance_after":44395,"source":{"system":"sec-edgar","filing":"0001192482-21-000063","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000063/edgar.xml","form_type":"4"}},{"id":2908097,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-01-13T21:08:12.000Z","date":"2021-01-11","kind":"tax_withholding","acquired":false,"shares":701,"price":21.18,"value":14847.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":45717,"source":{"system":"sec-edgar","filing":"0001192482-21-000058","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000058/edgar.xml","form_type":"4"}},{"id":3083482,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-07-14T20:06:23.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":1429,"price":17.01,"value":24307.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 22, 2019."}],"balance_after":46418,"source":{"system":"sec-edgar","filing":"0001192482-20-000621","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000621/edgar.xml","form_type":"4"}},{"id":3083481,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-07-14T20:06:23.000Z","date":"2020-07-10","kind":"tax_withholding","acquired":false,"shares":594,"price":16.73,"value":9937.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":47847,"source":{"system":"sec-edgar","filing":"0001192482-20-000621","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000621/edgar.xml","form_type":"4"}},{"id":3140611,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-05-20T20:18:25.000Z","date":"2020-05-18","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"8,000 shares under the option are exercisable. The option, initially representing a right to purchase a total of 25,600 shares, vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vested and became exercisable on February 10, 2020, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":17600,"derivative":{"exercise_price":15.9,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001192482-20-000350","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000350/edgar.xml","form_type":"4"}},{"id":3140610,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-05-20T20:18:25.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":8000,"price":24,"value":192000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019 and modified on March 5, 2020."}],"balance_after":48441,"source":{"system":"sec-edgar","filing":"0001192482-20-000350","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000350/edgar.xml","form_type":"4"}},{"id":3140609,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-05-20T20:18:25.000Z","date":"2020-05-18","kind":"exercise","acquired":true,"shares":8000,"price":15.9,"value":127200.0,"ownership":{"direct":true},"balance_after":56441,"source":{"system":"sec-edgar","filing":"0001192482-20-000350","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000350/edgar.xml","form_type":"4"}},{"id":3146994,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-05-15T20:15:46.000Z","date":"2020-05-13","kind":"sale","acquired":false,"shares":4434,"price":22.61,"value":100252.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019 and modified on March 5, 2020."}],"balance_after":48441,"source":{"system":"sec-edgar","filing":"0001192482-20-000346","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000346/edgar.xml","form_type":"4"}},{"id":3276585,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-02-12T21:27:06.000Z","date":"2020-02-10","kind":"tax_withholding","acquired":false,"shares":1966,"price":21.62,"value":42504.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":52875,"source":{"system":"sec-edgar","filing":"0001192482-20-000150","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000150/edgar.xml","form_type":"4"}},{"id":3284311,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-07T21:10:04.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2021, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":21250,"derivative":{"exercise_price":21.34,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":21250},"source":{"system":"sec-edgar","filing":"0001192482-20-000137","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000137/edgar.xml","form_type":"4"}},{"id":3284310,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-02-07T21:10:04.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":19125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2021, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":54841,"source":{"system":"sec-edgar","filing":"0001192482-20-000137","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000137/edgar.xml","form_type":"4"}},{"id":3309302,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-01-16T21:12:27.000Z","date":"2020-01-14","kind":"sale","acquired":false,"shares":1321,"price":23.87,"value":31532.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2019."}],"balance_after":35716,"source":{"system":"sec-edgar","filing":"0001192482-20-000038","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000038/edgar.xml","form_type":"4"}},{"id":3311481,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-01-14T21:27:43.000Z","date":"2020-01-10","kind":"tax_withholding","acquired":false,"shares":702,"price":23.3,"value":16356.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":37037,"source":{"system":"sec-edgar","filing":"0001192482-20-000036","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000036/edgar.xml","form_type":"4"}},{"id":3462419,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-07-12T20:08:47.000Z","date":"2019-07-11","kind":"sale","acquired":false,"shares":2857,"price":12.31,"value":35169.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019."}],"balance_after":37739,"source":{"system":"sec-edgar","filing":"0001192482-19-000312","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000312/edgar.xml","form_type":"4"}},{"id":3462418,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-07-12T20:08:47.000Z","date":"2019-07-10","kind":"tax_withholding","acquired":false,"shares":1190,"price":12.44,"value":14803.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":40596,"source":{"system":"sec-edgar","filing":"0001192482-19-000312","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000312/edgar.xml","form_type":"4"}},{"id":3683688,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2019-01-29T21:46:37.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":25600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2020, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":25600,"derivative":{"exercise_price":15.9,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":25600},"source":{"system":"sec-edgar","filing":"0001192482-19-000061","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000061/edgar.xml","form_type":"4"}},{"id":3683687,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-01-29T21:46:37.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":25600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2020, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":41786,"source":{"system":"sec-edgar","filing":"0001192482-19-000061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000061/edgar.xml","form_type":"4"}},{"id":3868563,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2018-07-12T20:41:20.000Z","date":"2018-07-10","kind":"grant","acquired":true,"shares":16186,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units in connection with the reporting person's promotion to Chief Commercial Officer of the issuer. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on July 10, 2019, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":16186,"source":{"system":"sec-edgar","filing":"0001192482-18-000337","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248218000337/edgar.xml","form_type":"4"}}]}